Table 2.
Cardiovascular risk assessment in rheumatoid arthritis and systemic lupus erythematosus patients
| Groups based on atherogenic index of plasma | Rheumatoid arthritis | Systemic lupus erythematosus | P value |
|---|---|---|---|
| Low risk (< 0.11) | 8 | 0 | 0.007 |
| Intermediate risk (0.11–0.24) | 2 | 1 | |
| High risk (> 0.24) | 5 | 8 |